Research that has been sponsored by pharmaceutical, medical device and biotechnology companies is often presented at scientific and medical conferences. However, practices vary between organizations and it can be difficult to follow both individual conference requirements and good publication practice guidelines. Until now, no specific guidelines or recommendations have been available to describe best practice for conference presentations. This document was developed by a working group of publication professionals and uploaded to PeerJ Preprints for consultation prior to publication; an additional 67 medical societies, medical conference sites and conference companies were also asked to comment. The resulting recommendations aim to complement current good publication practice and authorship guidelines, outline the general principles of best practice for conference presentations and provide recommendations around authorship, contributorship, financial transparency, prior publication and copyright, to conference organizers, authors and industry professionals. While the authors of this document recognize that individual conference guidelines should be respected, they urge organizers to consider authorship criteria and data transparency when designing submission sites and setting parameters around word/character count and content for abstracts. It is also important to recognize that conference presentations have different limitations to full journal publications, for example, in the case of limited audiences that necessitate refocused abstracts, or where lead authors do not speak the local language, and these have been acknowledged accordingly. The authors also recognize the need for further clarity regarding copyright of previously published abstracts and have made recommendations to assist with best practice.

No abstract

SummaryIt is relatively easy to begin policy documents with a general assertion that ethics will be followed. Less obvious is how to ensure that day‐to‐day activities are consonant with ethical standards. We suggest that using day‐to‐day publication activities as the driver for building policies and procedures can promote ethical practices from the ground up. Although basic principles of ethical publication practice may seem straightforward to some, for others this information may require explanation, interpretation and context. Effective policy development includes big‐picture items as well as more day‐to‐day tactical responsibilities such as those discussed below. Research questions, disciplinary practices, applications and team structures may vary. Thus, no single publication plan or policy solution is right for all teams. It is up to team members to review guidelines for best practices and find the optimal implementation for their situations. Experts in publication management, planning and writing can help large teams manage publication activities. These experts have an obligation to maintain and enhance their skills continually. A strong acumen in publication best practices will allow these publication professionals to better address any possible ethical dilemmas in the future.

This preprint document has been developed following discussions among the authors, all of 37 whom work within the medical communications field. These discussions have indicated a clear 38 need for guidance and consistency around conference abstracts and presentations, so we 39 propose various recommendations and welcome input from any interested individuals. Any 40 guidelines must be based on the principles of transparency, consistency and practicality, but we 41 note that specific congress requirements should always be followed. 42Research that has been sponsored* by commercial organizations (e.g. pharmaceutical, medical 45 device and biotech companies) is often presented at scientific and medical conferences. 46However, until now, no specific guidelines have been available to describe good practice for this 47

This preprint document has been developed following discussions among the authors, all of 37 whom work within the medical communications field. These discussions have indicated a clear 38 need for guidance and consistency around conference abstracts and presentations, so we 39 propose various recommendations and welcome input from any interested individuals. Any 40 guidelines must be based on the principles of transparency, consistency and practicality, but we 41 note that specific congress requirements should always be followed. 42Research that has been sponsored* by commercial organizations (e.g. pharmaceutical, medical 45 device and biotech companies) is often presented at scientific and medical conferences. 46However, until now, no specific guidelines have been available to describe good practice for this 47